vs
Side-by-side financial comparison of Inspirato Inc (ISPO) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $55.5M, roughly 1.0× Inspirato Inc). Inspirato Inc runs the higher net margin — -8.1% vs -83.0%, a 74.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -19.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -11.4%).
Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
ISPO vs RYTM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $57.3M |
| Net Profit | $-4.5M | $-47.5M |
| Gross Margin | 31.4% | 91.6% |
| Operating Margin | -8.0% | -82.2% |
| Net Margin | -8.1% | -83.0% |
| Revenue YoY | -19.6% | 36.9% |
| Net Profit YoY | -204.4% | -9.6% |
| EPS (diluted) | $-0.36 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | $55.5M | $51.3M | ||
| Q2 25 | $63.1M | $48.5M | ||
| Q1 25 | $65.9M | $32.7M | ||
| Q4 24 | $63.1M | $41.8M | ||
| Q3 24 | $69.1M | $33.3M | ||
| Q2 24 | $67.4M | $29.1M | ||
| Q1 24 | $80.2M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $-4.5M | $-52.9M | ||
| Q2 25 | $-5.3M | $-46.6M | ||
| Q1 25 | $1.6M | $-49.5M | ||
| Q4 24 | $-2.3M | $-43.3M | ||
| Q3 24 | $4.3M | $-43.6M | ||
| Q2 24 | $-8.7M | $-32.3M | ||
| Q1 24 | $1.3M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | 31.4% | 89.3% | ||
| Q2 25 | 27.5% | 88.6% | ||
| Q1 25 | 38.8% | 88.8% | ||
| Q4 24 | 34.7% | 90.9% | ||
| Q3 24 | 71.5% | 88.5% | ||
| Q2 24 | 24.0% | 89.9% | ||
| Q1 24 | 39.5% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | -8.0% | -102.6% | ||
| Q2 25 | -8.3% | -93.4% | ||
| Q1 25 | 2.5% | -143.7% | ||
| Q4 24 | -3.2% | -98.6% | ||
| Q3 24 | 9.8% | -132.0% | ||
| Q2 24 | -22.8% | -139.2% | ||
| Q1 24 | 3.0% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | -8.1% | -103.1% | ||
| Q2 25 | -8.4% | -96.1% | ||
| Q1 25 | 2.5% | -151.4% | ||
| Q4 24 | -3.6% | -103.6% | ||
| Q3 24 | 6.3% | -131.2% | ||
| Q2 24 | -12.9% | -110.9% | ||
| Q1 24 | 1.6% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $-0.36 | $-0.82 | ||
| Q2 25 | $-0.42 | $-0.75 | ||
| Q1 25 | $0.12 | $-0.81 | ||
| Q4 24 | $0.98 | $-0.71 | ||
| Q3 24 | $0.62 | $-0.73 | ||
| Q2 24 | $-2.33 | $-0.55 | ||
| Q1 24 | $-0.18 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-134.0M | $139.1M |
| Total Assets | $228.3M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | $13.7M | $416.1M | ||
| Q2 25 | $16.7M | $291.0M | ||
| Q1 25 | $16.4M | $314.5M | ||
| Q4 24 | $21.8M | $320.6M | ||
| Q3 24 | $13.5M | $298.4M | ||
| Q2 24 | $18.8M | $319.1M | ||
| Q1 24 | $22.6M | $201.2M |
| Q4 25 | — | $139.1M | ||
| Q3 25 | $-134.0M | $148.8M | ||
| Q2 25 | $-129.7M | $-11.9M | ||
| Q1 25 | $-125.2M | $18.9M | ||
| Q4 24 | $-129.9M | $21.7M | ||
| Q3 24 | $-134.6M | $11.2M | ||
| Q2 24 | $-35.2M | $39.3M | ||
| Q1 24 | $-27.5M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | $228.3M | $506.9M | ||
| Q2 25 | $252.6M | $372.7M | ||
| Q1 25 | $270.1M | $386.7M | ||
| Q4 24 | $273.9M | $392.3M | ||
| Q3 24 | $273.3M | $363.6M | ||
| Q2 24 | $301.7M | $381.8M | ||
| Q1 24 | $313.0M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $-25.4M |
| Free Cash FlowOCF − Capex | $-3.0M | — |
| FCF MarginFCF / Revenue | -5.4% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-31.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $-2.2M | $-26.6M | ||
| Q2 25 | $1.1M | $-23.3M | ||
| Q1 25 | $-6.6M | $-40.4M | ||
| Q4 24 | $-15.8M | $-18.8M | ||
| Q3 24 | $-13.7M | $-25.2M | ||
| Q2 24 | $-1.8M | $-29.1M | ||
| Q1 24 | $-7.2M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-3.0M | — | ||
| Q2 25 | $468.0K | — | ||
| Q1 25 | $-7.5M | — | ||
| Q4 24 | $-21.2M | — | ||
| Q3 24 | $-14.8M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-8.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | -5.4% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | -11.4% | — | ||
| Q4 24 | -33.7% | — | ||
| Q3 24 | -21.5% | — | ||
| Q2 24 | -5.5% | — | ||
| Q1 24 | -10.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -3.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -5.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
RYTM
Segment breakdown not available.
